Target intelligence / Profile preview

Catabolite activator protein–DNA complex (CAP–DNA)

Target
CAP–DNA
Molecular classification
Transcription factor, DNA-binding protein, cAMP-binding protein
01

Overview

The Catabolite activator protein–DNA complex (CAP–DNA complex) is a fundamental regulatory assembly in prokaryotic gene expression, primarily characterized in Escherichia coli (UniProt: P0ACJ8) [1]. The complex forms when the Catabolite Activator Protein (CAP), also known as the cAMP Receptor Protein (CRP), binds to its allosteric effector, cyclic AMP (cAMP), which induces a conformational change allowing the protein to bind specifically to DNA sequences [2]. This binding results in a significant bending of the DNA, often exceeding 90 degrees, which is a critical step for the recruitment and activation of RNA polymerase at various promoters (PDB: 1CGP) [3]. The CAP–DNA complex is the central mediator of carbon catabolite repression, a mechanism that enables bacteria to prioritize the utilization of glucose over other carbon sources [4]. Beyond its metabolic role, CAP-like proteins regulate the expression of virulence factors in several human pathogens, including Vibrio cholerae and Mycobacterium tuberculosis, making the complex a potential target for the development of novel antimicrobial therapies [5]. Research into this complex has provided foundational insights into the principles of allosteric regulation and protein-DNA recognition in molecular biology [2, 3]. Citations: [1] UniProt P0ACJ8; [2] Busby & Ebright (1999) J Mol Biol; [3] Schultz et al. (1991) Science; [4] Gorke & Stulke (2008) Nat Rev Microbiol; [5] Rickman et al. (2005) Mol Microbiol.

Other names
cAMP receptor protein–DNA complexCRP–DNA complexCatabolite gene activator protein–DNA complexCAP-DNA complexCatabolite activator proteincAMP receptor protein
02

Mechanism of action

Competitive inhibition of cAMP binding or allosteric modulation of DNA binding affinity

03

Biological functions

Transcriptional regulationCarbon catabolite repressionDNA bendingSignal transduction
04

Disease associations

Bacterial infection
05

Safety considerations

Potential for off-target effects on human cAMP-binding proteins such as Protein Kinase A (PKA) or Exchange Proteins Directly Activated by cAMP (EPACs)
06

Interacting drugs

Cyclic AMP

3 more in the full profile.

07

Biomarkers

Intracellular cAMP levels

Beyond the preview

Go deeper on Catabolite activator protein–DNA complex (CAP–DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catabolite activator protein–DNA complex (CAP–DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call